Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18167Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mantouvalou, M. | en |
| dc.contributor.author | Ralli, S. | en |
| dc.contributor.author | Arnaoutoglou, H. | en |
| dc.contributor.author | Tziris, G. | en |
| dc.contributor.author | Papadopoulos, G. | en |
| dc.date.accessioned | 2015-11-24T18:50:52Z | - |
| dc.date.available | 2015-11-24T18:50:52Z | - |
| dc.identifier.issn | 0001-5164 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18167 | - |
| dc.rights | Default Licence | - |
| dc.subject | Abdomen/surgery | en |
| dc.subject | Amides/*administration & dosage | en |
| dc.subject | Anesthesia Recovery Period | en |
| dc.subject | Anesthesia, Spinal/*methods | en |
| dc.subject | Anesthetics, Local | en |
| dc.subject | Bupivacaine/*administration & dosage/analogs & derivatives | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Injections, Spinal | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Pain Measurement | en |
| dc.subject | Prospective Studies | en |
| dc.subject | Treatment Outcome | en |
| dc.title | Spinal anesthesia: comparison of plain ropivacaine, bupivacaine and levobupivacaine for lower abdominal surgery | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/18652102 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2008 | - |
| heal.abstract | This study was performed to compare the anesthetic efficacy and safety of three local anesthetic agents: racemic bupivacaine and its two isomers: ropivacaine and levobupivacaine, in patients undergoing lower abdominal surgery. One hundred-twenty patients, ASA I-III, were randomized to receive an intrathecal injection of one of three local anesthetic solutions. Group A (n = 40) received 3 ml of isobaric bupivacaine 5 mg/ml (15 mg). Group B (n = 40) received 3 ml of isobaric ropivacaine 5 mg/ml (15 mg). Group C (n = 40) received 3 ml of isobaric levobupivacaine 5 mg/ml (15 mg). The onset and duration of sensory block at dermatome level T8, maximum upper spread of sensory block, time for 2-segment regression of sensory block as well as the onset, intensity and duration of motor block were recorded, as were any adverse effects, such as bradycardia, hypotension, hypoxia, tremor, nausea and/or vomiting. Time to unassisted standing up and voluntary micturition was also recorded. The onset of motor block was significantly faster in the bupivacaine group compared with that in the ropivacaine group and almost the same of that in the levobupivacaine group (P < 0.05). Ropivacaine presented a shorter duration of both motor and sensory block than bupivacaine and levobupivacaine (P < 0.05). Bupivacaine required more often the use of a vasoactive drug (ephedrine) compared to both ropivacaine and levobupivacaine and of a sympathomimetic drug (atropine) compared to the ropivacaine group. | en |
| heal.journalName | Acta Anaesthesiol Belg | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
